Home/Recalls/CANADA-61613
Health CanadaGeneral Alert

Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fi...

Published: September 30, 2020Recall ID: 61613Category: generalCountry: Canada

Product Description & Identification

Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market

Additional Source Details

FieldValue
N I D61613
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/allergan-inc-voluntarily-withdraws-its-drug-fibristal-used-treat-uterine-fibroids
Title Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
Archived0
CategoryDrugs
Last updated2020-09-30
OrganizationCommunications and Public Affairs Branch

Overview

  • Recalling FirmCommunications and Public Affairs Branch
Official Agency Alert